{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:29:22Z","timestamp":1782512962350,"version":"3.54.5"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000008846","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T02:43:10Z","timestamp":1512614590000},"page":"e8846","source":"Crossref","is-referenced-by-count":46,"title":["Severe infections in sarcoidosis"],"prefix":"10.1097","volume":"96","author":[{"given":"Am\u00e9lie","family":"Dur\u00e9ault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Chapelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Biard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Savey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Pourcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu Resche","family":"Rigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-40-20210226","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"R2-40-20210226","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-40-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.10","article-title":"Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics","volume":"305","author":"Iannuzzi","year":"2011","journal-title":"JAMA"},{"key":"R4-40-20210226","doi-asserted-by":"crossref","first-page":"e9088","DOI":"10.1371\/journal.pone.0009088","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PloS One"},{"key":"R5-40-20210226","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R6-40-20210226","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.autrev.2014.10.006","article-title":"The spectrum of opportunistic diseases complicating sarcoidosis","volume":"14","author":"Jamilloux","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R7-40-20210226","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/qjmed\/hct052","article-title":"Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases","volume":"106","author":"Bernard","year":"2013","journal-title":"QJM"},{"key":"R8-40-20210226","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/WNL.0000000000000318","article-title":"Progressive multifocal leukoencephalopathy in patients with sarcoidosis","volume":"82","author":"Jamilloux","year":"2014","journal-title":"Neurology"},{"key":"R9-40-20210226","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/qjmed\/hci073","article-title":"Fungal infections as a complication of therapy for sarcoidosis","volume":"98","author":"Baughman","year":"2005","journal-title":"QJM"},{"key":"R10-40-20210226","first-page":"1360","article-title":"Fungal infections complicating pulmonary sarcoidosis","volume":"152","author":"Rubinstein","year":"1985","journal-title":"J Infect Dis"},{"key":"R11-40-20210226","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur Respir J"},{"key":"R12-40-20210226","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","article-title":"Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly","volume":"50","author":"Galloway","year":"2011","journal-title":"Rheumatology"},{"key":"R13-40-20210226","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R14-40-20210226","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"R15-40-20210226","first-page":"72","article-title":"Pneumocystis jirovecii pneumonia in patients with autoimmune disease on high-dose glucocorticoid","volume":"21","author":"Chew","year":"2015","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"R16-40-20210226","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/archinte.1976.03630120008006","article-title":"The infectious complications of sarcoidosis: a current perspective","volume":"136","author":"Winterbauer","year":"1976","journal-title":"Arch Intern Med"},{"key":"R17-40-20210226","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0761-8425(04)71582-X","article-title":"Opportunistic infections and sarcoidosis","volume":"21","author":"Girard","year":"2004","journal-title":"Rev Mal Respir"},{"key":"R18-40-20210226","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1212\/WNL.0000000000000902","article-title":"Progressive multifocal leukoencephalopathy in patients with sarcoidosis","volume":"83","author":"Lefaucheur","year":"2014","journal-title":"Neurology"},{"key":"R19-40-20210226","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.lpm.2008.11.008","article-title":"Complications infectieuses de la sarco\u00efdose","volume":"38","author":"Dhote","year":"2009","journal-title":"Presse M\u00e9dicale"},{"key":"R20-40-20210226","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.nrl.0000250948.04681.96","article-title":"Review of progressive multifocal leukoencephalopathy and natalizumab","volume":"12","author":"Aksamit","year":"2006","journal-title":"Neurologist"},{"key":"R21-40-20210226","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1378\/chest.83.3.572","article-title":"THe association of progressive multifocal leukoencephalopathy and sarcoidosis","volume":"83","author":"Rosenbloom","year":"1983","journal-title":"Chest"},{"key":"R22-40-20210226","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1749-6632.1974.tb14469.x","article-title":"Our evolving understanding of progressive multifocal leukoencephalopathy","volume":"230","author":"Richardson","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"R23-40-20210226","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ajt.12947","article-title":"Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis","volume":"15","author":"Iriart","year":"2015","journal-title":"Am J Transplant"},{"key":"R24-40-20210226","doi-asserted-by":"crossref","first-page":"g1532","DOI":"10.1136\/bmj.g1532","article-title":"Nested case-control studies: advantages and disadvantages","volume":"348","author":"Sedgwick","year":"2014","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:43:49Z","timestamp":1620960229000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712080-00040"}},"subtitle":["Incidence, predictors and long-term outcome in a cohort of 585 patients"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":24,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008846","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}